PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: GTCbio - Biopharmaceutical Conference

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Arnold Gelb with Quest Dx to Talk at Molecular Diagnostics Conference, March 7-8 in Philadelphia - Arnold Gelb, Senior Biomarker Pathologist at Quest Diagnostics Clinical Trials, will give a presentation on “Applications of Biomarkers in Molecular Pathology to Therapeutic Development” at GTCbio's
Arnold Gelb with Quest Dx to Talk at Molecular Diagnostics Conference, March 7-8 in Philadelphia

 

NewswireToday - /newswire/ - Monrovia, CA, United States, 2011/01/18 - Arnold Gelb, Senior Biomarker Pathologist at Quest Diagnostics Clinical Trials, will give a presentation on “Applications of Biomarkers in Molecular Pathology to Therapeutic Development” at GTCbio's.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Arnold Gelb, Senior Biomarker Pathologist at Quest Diagnostics Clinical Trials, will give a presentation on “Applications of Biomarkers in Molecular Pathology to Therapeutic Development.” Molecular pathology is a newly established, “cross-over” discipline focused on the study of disease through examination of molecules in tissues and body fluids. This discipline includes the development, design, and validation of biomarker assays that may be useful for rendering a diagnosis, establishing patient prognosis, and monitoring treatment response and disease progression. By helping to diagnose and stratify disease and identify patients likely to respond to specific therapies, biomarkers can facilitate the use of molecularly-targeted therapeutics and thus expand the field of personalized medicine. Several case studies will be presented that illustrate the application of new and emerging biomarker assays in different clinical trial phases and show how a central laboratory can work with pharmaceutical and biotechnology companies to develop biomarker assays that support the development of targeted therapies. Proposed solutions to obstacles in the field, such as lack of assay standardization, will also be discussed.

Arnold Gelb is the Senior Biomarker Pathologist at Quest Diagnostics Clinical Trials, where his work focuses on the development and application of biomarkers to clinical trials. He was previously Director of Pathology at Pathway Diagnostics where he also developed novel tissue biomarker assays. Before that he served in various experimental and/or clinical pathology roles at Novartis/Chiron, Deltagen, DNAX (now part of Merck Research Laboratories) and UCSF. He has authored over 40 scientific publications and a book chapter in a molecular medicine text. He received his M.D. from Stanford University and M.S. from Northwestern University.

Come and join the discussion at GTCbio`s Molecular Diagnostics Conference to be held in Philadelphia, PA on March 7-8, 2011. Network with colleagues in academia, industry, and healthcare to share and learn about the latest technologies and novel discoveries in the diagnostics field. Gain insight into the issues and challenges facing the healthcare industry and hear success stories from industry leaders.

Presenting organizations include Merck, Genentech, Illumina, Quest Diagnostics, On-Q-Ity, OncoVista, Caprion Proteomics and other leaders in the diagnostics industry. For more information, visit GTCbio.com/.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: GTCbio - Biopharmaceutical Conference

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Arnold Gelb with Quest Dx to Talk at Molecular Diagnostics Conference, March 7-8 in Philadelphia

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: GTCbio.com 
626-256-6405 infogtcbio[.]gtcbio.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any GTCbio - Biopharmaceutical Conference securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From GTCbio - Biopharmaceutical Conference / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

BD Announces Adoption of Windows 10 ‘Internet of Things’ for the Pyxis™ ES System
Greenphire Named to Deloitte 2016 Technology Fast 500™
Genentech Showcases New Clinical Data Across a Variety of Blood Diseases at American Society of Hematology 2016 Annual Meeting
BD Collaborates with JDRF to Focus on Extended Wear Innovations for Insulin Infusion Delivery
BD Launches First Syringe Designed for Use with Humulin® R U-500 Insulin
MDxHealth Announces Unique CPT Code Awarded for ConfirmMDx from the American Medical Association
BD MAX™ Vaginal Panel Receives FDA Market Authorization to Detect Most Common Causes of Vaginal Infections
Greenphire Receives EU-US Privacy Shield Certification
The 2016 Georges Mathé Prize Recognizes Research on the Immunological Determinants of the Response to Breast Cancer Treatment
MDxHealth Announces Agreement with HIFU CLINIC Prostate Cancer Center for Distribution of SelectMDx in Poland
First Patient in Malaysia Receives TheraSphere™ Radioembolisation Therapy
FDA Approves Genentech’s Lucentis® (Ranibizumab Injection) Prefilled Syringe
BTG and Mirada Medical Announce CE Mark Certification for Simplicit90Y Dosimetry Software in Europe
FDA Grants Priority Review to Genentech’s Lucentis® (Ranibizumab Injection) Supplemental Biologics License Application
Genentech’s TECENTRIQ® (Atezolizumab) Shows Significant Survival Advantage Compared to Chemotherapy

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  JobsWare.com

Visit  Triggr & Bloom





 
  ©2016 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)